Recently added
This page was added on 16 December 2022.
Updates made
This page was updated on [date-counter-updated-date]. View history of updates
Sponsor
Sanofi Pasteur Pty Ltd
Administration route
Intramuscular injection
Vaccine group
Quadrivalent meningococcal conjugate vaccines
Description:
Registered for use in people aged ≥12 months
MenACWY-TT – quadrivalent meningococcal (serogroups A, C, W, Y)-tetanus toxoid conjugate vaccine
Clear, colourless, sterile, preservative-free solution
Each 0.5 mL dose of vaccine contains:
- 10 µg meningococcal polysaccharide serogroup A
- 10 µg meningococcal polysaccharide serogroup C
- 10 µg meningococcal polysaccharide serogroup W
- 10 µg meningococcal polysaccharide serogroup Y
- Each of the four polysaccharides is conjugated to tetanus toxoid (approximately 55 µg/dose)
For Product Information and Consumer Medicine Information about MenQuadfi visit the Therapeutic Goods Administration website.
Related diseases
Page history
Last updated
Last reviewed